Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening

5 Jan 2024

Abstract excerpt

Abstract Functional precision medicine (FPM) aims to optimize patient-specific drug selection based on the unique characteristics of their cancer cells. Recent advancements in high throughput ex vivo drug profiling have accelerated interest in FPM. Here, we present a proof-of-concept study for an integrated experimental system that incorporates ex vivo treatment response with a single-cell gene expression output...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to CAR-T cell therapy research
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38288374
DOI: 10.1093/nargab/lqae001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screeningPMID 38288374Read ↗

COMPARISON OF HIGH-THROUGHPUT SINGLE-CELL RNA-SEQ METHODS FOR EX VIVO DRUG SCREENINGSemantic proximity Read ↗

Predicting drug response from single-cell expression profiles of tumoursSemantic proximity Read ↗

Integration of Pan-Cancer Cell Line and Single-Cell Transcriptomic Profiles Enables Inference of Therapeutic Vulnerabilities in Heterogeneous TumorsSemantic proximity Read ↗

scDrugAtlas: an integrative single-cell drug response database for dissecting tumor heterogeneity in therapeutic efficacySemantic proximity Read ↗

Benchmarking full-length transcript single cell mRNA sequencing protocolsSemantic proximity Read ↗

Deconvolution of Cell Type-Specific Drug Responses in Human Tumor Tissue with Single-Cell RNA-seqSemantic proximity Read ↗

Single-cell analyses to tailor treatmentsSemantic proximity Read ↗

Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signaturesSemantic proximity Read ↗

scPharm: identifying pharmacological subpopulations of single cells for precision medicine in cancersSemantic proximity Read ↗

Predicting Pre-treatment Resistance or Post-treatment Effect? A Systematic Benchmarking of Single-Cell Drug Response ModelsSemantic proximity Read ↗

Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signaturesSemantic proximity Read ↗

Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seqSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.